GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 9.31

Change

+0.07 (+0.76)%

Market Cap

N/A

Volume

0.19M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.11 (+0.81%)

USD 81.50B
VTR Ventas Inc

+0.45 (+0.68%)

USD 27.31B
DOC Healthpeak Properties Inc

+0.20 (+0.89%)

USD 16.16B
CTRE CareTrust REIT Inc.

+0.89 (+2.79%)

USD 4.68B
AHR American Healthcare REIT, Inc.

+0.62 (+2.35%)

USD 4.03B
NHI National Health Investors Inc

+0.98 (+1.27%)

USD 3.32B
LTC LTC Properties Inc

+0.92 (+2.42%)

USD 1.56B
UHT Universal Health Realty Income..

+0.43 (+1.08%)

USD 0.57B
CHCT Community Healthcare Trust Inc

+1.19 (+6.70%)

USD 0.49B
GMRE-PA Global Medical REIT Inc

+0.05 (+0.20%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

+0.09 (+0%)

USD 0.25B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.13% 14% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.13% 29% F 27% F
Trailing 12 Months  
Capital Gain 5.80% 29% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.80% 43% F 39% F
Trailing 5 Years  
Capital Gain -22.48% 46% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.48% 46% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain -3.47% 36% F 19% F
Dividend Return 3.17% 43% F 38% F
Total Return 6.65% 86% B+ 90% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.88% 43% F 43% F
Risk Adjusted Return 12.76% 36% F 31% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.